Biocon denosumab biosimilars have secured a major regulatory win, with Health Canada granting a Notice of Compliance (NOC) for two of the company’s products—Bosaya and Vevzuo—on April 3, 2026. The approval marks a significant step as Biocon...
The Government of India is stepping up efforts to strengthen healthcare infrastructure while focusing on the early diagnosis of non-communicable diseases (NCDs), Union Health Minister Jagat Prakash Nadda said during a recent policy discussion.
Bharat Parenterals Ltd said its subsidiary, Innoxel Lifesciences, has received five observations from the United States Food and Drug Administration (USFDA) following a recent USFDA inspection at its Vadodara facility.
India is set to take a major step toward improving end-of-life support as the Indian Council of Medical Research rolls out a palliative care study across multiple states. Announced today, this initiative aims to address a long-standing gap in the...
NCR’s fake Mounjaro problem is growing fast—and most people don’t see it coming. In fact, it is no longer limited to shady corners of the market. It’s now tied to a Rs 70 lakh cache of counterfeit injections recently uncovered, pointing to...
In a significant step toward transforming pediatric critical care, Aster CMI Hospital today announced the launch of PEARL (Pediatric Emergency and Advanced Response for Liver Care) – Karnataka’s first dedicated Pediatric Liver Intensive Care Unit...
OneSource Speciality Pharma has said that its partner, Orbicular Pharmaceutical Technologies, along with a US-based front-end partner, has received tentative approval from the U.S. Food and Drug Administration for a generic version of semaglutid...
A Gujarat-based non-governmental organisation has called on the Centre to bring nutraceuticals regulation India under stricter drug control, raising concerns about product quality issues, consumer safety risks, and pricing concerns in healthca...
Rusan Pharma has achieved a significant global milestone by receiving Good Manufacturing Practice (GMP) approval from Pharmaceuticals and Medical Devices Agency (PMDA), one of the world’s most stringent drug regulators.
World Liver Day 2026 highlights a growing concern—liver damage is no longer driven by alcohol alone.Experts say everyday choices around food, sleep, and stress are now major contributors to declining liver health.